Mylan Gets FDA Approval for Generic Version of Zyban

Mylan said its subsidiary Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Bupropion Hydrochloride Extended-release Tablets USP, 150 mg, the generic version of GlaxoSmithKline’s smoking cessation aid, Zyban.
RTTNews